Insider Transactions Reported by 17 Insiders of Applied Therapeutics, Inc.

Location: New York, NY

Key facts

Applied Therapeutics, Inc. has 17 insiders with reported activity on this page.
Net insider value flow over the last year: -$4,816.
Recent transaction rows are available for direct filing-level review.

Change

Buy value: ; sell value: $4,816.
Net share flow: -43,000.

Research use

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to selling over the last 12 months. Net value: -$4,816.

Buys

Shares: 0

Insiders: 0

Sells

$4,816

Shares: 43,000

Insiders: 1

Net

-$4,816

Shares: -43,000

Insiders: -1

Window (months)	Sell shares	Buy $	Sell $	Net $
0-3	0	$0	$0	$0
3-6	43,000	$0	$4,816	-$4,816
6-9	0	$0	$0	$0
9-12	0	$0	$0	$0

Applied Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
Shoshana Shendelman	President and CEO, Director	$32,251,639			Mixed	05 Aug 2024
ALEXANDRIA REAL ESTATE EQUITIES, INC.	10%+ Owner	$24,825,526			Filing P/S	04 Jun 2024
Adam Hansard	Chief Commercial Officer	$3,950,433			Filing P/S	14 Mar 2024
John Johnson	Executive Chairman, Director	$2,915,000			Mixed	19 Dec 2024
Joel S. Marcus	Director	$2,113,275			Mixed	06 Jun 2024
Charles Silberstein	Chief Financial Officer	$400,053			Mixed	07 Jan 2022
Riccardo Perfetti	Chief Medical Officer	$391,780			Filing P/S	04 Mar 2025
Steven A. Ortega	Principal Accounting Officer	$120,720			Mixed	15 Nov 2022
Evan Prescott Bailey	Chief Medical Officer	$0			Mixed	19 Dec 2025
Constantine Chinoporos	Chief Operating Officer and Chief Business Officer	$0			Mixed	19 Dec 2025
Corwin Dale Hooks	Chief Commercial Officer	$0			Mixed	19 Dec 2025
Teena Lerner	Director	$0			Mixed	03 Feb 2026
Stacy J. Kanter	Director	$0	-$4,816	-100%	Mixed	03 Feb 2026
Jay S. Skyler	Director	$0			Mixed	03 Feb 2026
Leslie D. Funtleyder	Chief Financial Officer, Director	$0			Mixed	01 Jan 2026
Chids Mahadevan	Title: Senior Vice President of Finance (Interim Principal Financial Officer)				Mixed	02 Aug 2022
Catherine Thorpe	Chief Accounting Officer				Mixed	16 Jun 2023

Top shareholders of Applied Therapeutics, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
T. Rowe Price Investment Management, Inc.	13D/G	—	15%	21,403,300	$12,946,856	+$1,644,911	30 Sep 2025	13D/G
Alyeska Investment Group, L.P.	13D/G	—	5.8%	6,707,497	$2,615,924	$0	31 Dec 2024	13D/G
ALEXANDRIA REAL ESTATE EQUITIES, INC.	3/4/5 13D/G	10%+ Owner	4.3% from 13D/G	7,355,077 mixed-class rows	$24,825,526	—	04 Jun 2024	3/4/5 13D/G
Propel Bio Management, LLC	13D/G	—	4.2%	6,015,394	$1,564,002	$0	29 Dec 2025	13D/G
Venrock Healthcare Capital Partners III, L.P.	13D/G	—	4.1%	5,567,709	$2,171,407	-$2,432,661	31 Mar 2025	13D/G
BlackRock, Inc.	13D/G	—	3.7%	5,219,475	$1,003,183	-$783,523	30 Jun 2025	13D/G
VANGUARD GROUP INC	13D/G	The Vanguard Group	3.3%	4,734,013	$1,473,225	-$359,492	30 Jun 2025	13D/G
Schonfeld Strategic Advisors LLC	13D/G	—	3.3%	4,676,097	$1,823,678	-$1,596,482	31 Mar 2025	13D/G
MORGAN STANLEY	13D/G	—	2.5%	2,858,931	$1,114,983	-$2,323,072	31 Jan 2025	13D/G
PERCEPTIVE ADVISORS LLC	13D/G	—	2.4%	2,860,000	$1,115,400	$0	31 Dec 2024	13D/G
FRANKLIN RESOURCES INC	13D/G	—	1.7%	2,003,400	$781,326	-$1,871,029	31 Dec 2024	13D/G
JANUS HENDERSON GROUP PLC	13D/G	—	0.02%	35,791	$13,958	-$4,706,957	31 Dec 2024	13D/G
Shoshana Shendelman	3/4/5	President and CEO, Director	— class O/S missing	5,438,725	$32,251,639	—	05 Aug 2024	3/4/5
Adam Hansard	3/4/5	Chief Commercial Officer	— class O/S missing	732,919	$3,950,433	—	14 Mar 2024	3/4/5
John Johnson	3/4/5	Executive Chairman, Director	— mixed-class rows	1,500,000 mixed-class rows	$2,915,000	—	19 Dec 2024	3/4/5
Joel S. Marcus	3/4/5	Director	— class O/S missing	498,414	$2,113,275	—	06 Jun 2024	3/4/5
Charles Silberstein	3/4/5	Chief Financial Officer	— mixed-class rows	215,603 mixed-class rows	$400,053	—	07 Jan 2022	3/4/5
Riccardo Perfetti	3/4/5	Chief Medical Officer	— class O/S missing	890,409	$391,780	—	04 Mar 2025	3/4/5
Steven A. Ortega	3/4/5	Principal Accounting Officer	— class O/S missing	55,404	$120,720	—	15 Nov 2022	3/4/5
Chids Mahadevan	3/4/5	Title: Senior Vice President of Finance (Interim Principal Financial Officer)	— class O/S missing	8,824	—	—	02 Aug 2022	3/4/5

Recent Insider Transactions by Companies or Individuals for Applied Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Stacy J. Kanter	APLT	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-42,500	0	03 Feb 2026	Direct
Stacy J. Kanter	APLT	Common Stock	Disposed to Issuer	-34.6%			-22,500	42,500	03 Feb 2026	Direct
Stacy J. Kanter	APLT	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-263,690	0	03 Feb 2026	Direct
Constantine Chinoporos	APLT	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-57,111	0	03 Feb 2026	Direct
Constantine Chinoporos	APLT	Common Stock	Disposed to Issuer	-94.6%			-1,000,000	57,111	03 Feb 2026	Direct
Leslie D. Funtleyder	APLT	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-152,959	0	03 Feb 2026	Direct
Leslie D. Funtleyder	APLT	Common Stock	Disposed to Issuer	-94%			-2,375,000	152,959	03 Feb 2026	Direct
Leslie D. Funtleyder	APLT	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-254,192	0	03 Feb 2026	Direct
Evan Prescott Bailey	APLT	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-60,901	0	03 Feb 2026	Direct
Evan Prescott Bailey	APLT	Common Stock	Disposed to Issuer	-95.3%			-1,235,915	60,901	03 Feb 2026	Direct
Evan Prescott Bailey	APLT	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-24,414	0	03 Feb 2026	Direct
Teena Lerner	APLT	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-82,922	0	03 Feb 2026	Direct
Teena Lerner	APLT	Common Stock	Disposed to Issuer	-21.3%			-22,500	82,922	03 Feb 2026	Direct
Teena Lerner	APLT	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-287,631	0	03 Feb 2026	Direct
Corwin Dale Hooks	APLT	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-5,753	0	03 Feb 2026	Direct
Corwin Dale Hooks	APLT	Common Stock	Disposed to Issuer	-99.3%			-862,500	5,753	03 Feb 2026	Direct
Jay S. Skyler	APLT	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-42,500	0	03 Feb 2026	Direct
Jay S. Skyler	APLT	Common Stock	Disposed to Issuer	-34.6%			-22,500	42,500	03 Feb 2026	Direct
Jay S. Skyler	APLT	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-263,690	0	03 Feb 2026	Direct
Leslie D. Funtleyder	APLT	Common Stock	Award	12.6%			150,000	1,340,459	01 Jan 2026	Direct
Constantine Chinoporos	APLT	Common Stock	Award	70.6%			437,500	1,057,111	19 Dec 2025	Direct
Leslie D. Funtleyder	APLT	Common Stock	Award	88.6%			1,187,500	2,527,959	19 Dec 2025	Direct
Evan Prescott Bailey	APLT	Common Stock	Award	50.9%			437,500	1,296,816	19 Dec 2025	Direct
Corwin Dale Hooks	APLT	Common Stock	Award	56.2%			312,500	868,253	19 Dec 2025	Direct
Stacy J. Kanter	APLT	Common Stock	Sale	-39.8%	$4,816	$0.1120	-43,000	65,000	16 Dec 2025	Direct
Leslie D. Funtleyder	APLT	Common Stock	Award	14.4%			150,000	1,190,459	01 Oct 2025	Direct
Leslie D. Funtleyder	APLT	Common Stock	Award	19.1%			150,000	937,121	01 Jul 2025	Direct
Evan Prescott Bailey	APLT	Common Stock	Award	55.4%			300,000	841,669	15 Jun 2025	Direct
Leslie D. Funtleyder	APLT	Common Stock	Award	23.5%			150,000	787,121	09 Jun 2025	Direct
Teena Lerner	APLT	Stock Option (Right to Buy)	Award				200,000	200,000	09 Jun 2025	Direct
Stacy J. Kanter	APLT	Stock Option (Right to Buy)	Award				200,000	200,000	09 Jun 2025	Direct
Jay S. Skyler	APLT	Stock Option (Right to Buy)	Award				200,000	200,000	09 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.